Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Eisinger

Showing results (11-20 of 100) with videos related to

Pageof 10
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 19, 2005
The choice of bilateral prophylactic mastectomyF Eisinger, L Huiart, H Sobol
Lancet (London, England)|October 22, 1994
Evidence for a third breast-cancer susceptibility geneH Sobol, D Birnbaum, F Eisinger
Journal of the National Cancer Institute|September 21, 2000
Re: Biologic characteristics of interval and screen-detected breast cancersF Eisinger, C Juliain-Reynier, H Sobol
Annales De Gastroenterologie Et D'Hepatologie|March 1, 1995
[Genetics and screening perspectives in subjects at risk]F Eisinger, J F Seitz, H Sobol
Lancet (London, England)|June 26, 2001
Tamoxifen's effect in women with breast cancerF Eisinger, C Julian-Reynier, H Sobol
Bulletin Du Cancer|July 21, 2000
[Knowledge and management of psychological side effects of chemotherapies]L Auroy, F Eisinger, C Julian-Reynier
Bulletin Du Cancer|July 1, 1995
[Medical chemoprevention of cancers. From the point of view of social sciences]P Bourret, F Eisinger, J P Moatti
Lancet (London, England)|June 10, 1995
Histoprognostic grade in BRCA1-associated breast cancerJ Jacquemier, F Eisinger, D Birnbaum, et al.
Gut|December 14, 2004
An alternative to prophylactic colectomy for colon cancer prevention in HNPCC syndromeS Olschwang, P Laurent-Puig, F Eisinger, et al.
Lancet (London, England)|March 27, 1999
Cultural basis for differences between US and French clinical recommendations for women at increased risk of breast and ovarian cancerF Eisinger, G Geller, W Burke, et al.
Pageof 10

Showing results (11-20 of 100) with videos related to

Sort By:
Pageof 10
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 19, 2005
The choice of bilateral prophylactic mastectomyF Eisinger, L Huiart, H Sobol
Lancet (London, England)|October 22, 1994
Evidence for a third breast-cancer susceptibility geneH Sobol, D Birnbaum, F Eisinger
Journal of the National Cancer Institute|September 21, 2000
Re: Biologic characteristics of interval and screen-detected breast cancersF Eisinger, C Juliain-Reynier, H Sobol
Annales De Gastroenterologie Et D'Hepatologie|March 1, 1995
[Genetics and screening perspectives in subjects at risk]F Eisinger, J F Seitz, H Sobol
Lancet (London, England)|June 26, 2001
Tamoxifen's effect in women with breast cancerF Eisinger, C Julian-Reynier, H Sobol
Bulletin Du Cancer|July 21, 2000
[Knowledge and management of psychological side effects of chemotherapies]L Auroy, F Eisinger, C Julian-Reynier
Bulletin Du Cancer|July 1, 1995
[Medical chemoprevention of cancers. From the point of view of social sciences]P Bourret, F Eisinger, J P Moatti
Lancet (London, England)|June 10, 1995
Histoprognostic grade in BRCA1-associated breast cancerJ Jacquemier, F Eisinger, D Birnbaum, et al.
Gut|December 14, 2004
An alternative to prophylactic colectomy for colon cancer prevention in HNPCC syndromeS Olschwang, P Laurent-Puig, F Eisinger, et al.
Lancet (London, England)|March 27, 1999
Cultural basis for differences between US and French clinical recommendations for women at increased risk of breast and ovarian cancerF Eisinger, G Geller, W Burke, et al.
Pageof 10